Cargando…
Inhibition of Heat Shock-Induced H3K9ac Reduction Sensitizes Cancer Cells to Hyperthermia
Heat stress, clinically known as hyperthermia, is a promising adjunctive modality in cancer treatment. However, the efficacy of hyperthermia as a monotherapy is limited and the underlying mechanism remains poorly understood. Targeting histone modifications is an emerging strategy for cancer therapy,...
Autores principales: | Lin, Huiyun, Song, Yihui, Song, Lingjun, Geng, Zilong, Cheng, Runtan, Lei, Yinrui, Guo, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539700/ https://www.ncbi.nlm.nih.gov/pubmed/37781518 http://dx.doi.org/10.7150/ijbs.86384 |
Ejemplares similares
-
Hyperthermia and the heat-shock proteins of HeLa cells.
por: Burdon, R. H., et al.
Publicado: (1982) -
Evaluation of the Heat Shock Protein 90 Inhibitor Ganetespib as a Sensitizer to Hyperthermia-Based Cancer Treatments
por: Scutigliani, Enzo M., et al.
Publicado: (2022) -
Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells
por: Tjeertes, Jorrit V, et al.
Publicado: (2009) -
Immune Sensitization to the 60 kD Heat Shock Protein and Pregnancy Outcome
por: Neuer, A., et al.
Publicado: (1997) -
Expression of DNMTs and H3K9ac in Ameloblastoma and Ameloblastic Carcinoma
por: do Amaral-Silva, Gleyson Kleber, et al.
Publicado: (2021)